OTCMKTS:DDRT - DanDrit Biotech USA SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Sign in or create an account to add this stock to your watchlist.
$6.05 0.00 (0.00 %)
(As of 03/16/2018)
Previous Close$6.05
Today's Range$6.00 - $6.05
52-Week Range$1.05 - $7.10
Volume30,875 shs
Average Volume12,872 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

DanDrit Biotech USA (OTCMKTS:DDRT) SEC Filings

DateFilerForm TypeView
05/24/2019
2:39 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/23/2019
4:39 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/16/2019
5:12 AM
DanDrit Biotech USA (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/16/2019
5:06 AM
DanDrit Biotech USA (Filer)
Form NT 10-Q
View Filing
05/01/2019
4:09 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/07/2019
11:36 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/28/2019
12:46 PM
DanDrit Biotech USA (Issuer)
Puche Luisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/11/2019
7:25 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/11/2019
4:37 PM
DanDrit Biotech USA (Issuer)
Gronfeldt-Sorensen Henrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/11/2019
4:26 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/07/2019
7:30 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2019
8:44 PM
Dybul Mark (Reporting)
DanDrit Biotech USA (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2019
8:43 PM
DanDrit Biotech USA (Issuer)
Sandler Carl Forest Jr (Reporting)
William Anderson Wittekind (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/28/2018
6:11 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/07/2018
12:46 PM
Dybul Mark (Reporting)
DanDrit Biotech USA (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/07/2018
9:49 AM
DanDrit Biotech USA (Filer)
Form CERT
View Filing
12/06/2018
2:55 PM
DanDrit Biotech USA (Filer)
Form 8-A12B
View Filing
12/06/2018
10:15 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/08/2018
11:13 AM
Debruyne Luc (Reporting)
DanDrit Biotech USA (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
11/07/2018
8:13 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/07/2018
8:13 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/07/2018
8:13 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/07/2018
8:12 PM
DanDrit Biotech USA (Issuer)
Sindlev Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/05/2018
4:20 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/29/2018
4:20 PM
DanDrit Biotech USA (Filer)
Form 10-K/A
View Filing
09/28/2018
8:58 PM
DanDrit Biotech USA (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
09/28/2018
8:55 PM
DanDrit Biotech USA (Filer)
Form NT 10-K
View Filing
09/27/2018
12:04 PM
Dybul Mark (Reporting)
DanDrit Biotech USA (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/27/2018
5:43 AM
DanDrit Biotech USA (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/27/2018
5:42 AM
D An Evelyn (Reporting)
DanDrit Biotech USA (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/18/2018
1:44 PM
D An Evelyn (Reporting)
DanDrit Biotech USA (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/14/2018
1:13 PM
DanDrit Biotech USA (Issuer)
Sandler Carl Forest Jr (Reporting)
William Anderson Wittekind (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/10/2018
11:35 AM
Dybul Mark (Reporting)
DanDrit Biotech USA (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
09/04/2018
12:35 PM
DanDrit Biotech USA (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
07/18/2018
7:18 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/10/2018
5:02 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/02/2018
7:51 AM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/25/2018
4:00 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2018
3:50 PM
DanDrit Biotech USA (Issuer)
Leire, Eric Jean Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2018
4:27 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/23/2018
4:15 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/08/2018
8:33 PM
DanDrit Biotech USA (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
01/18/2018
3:22 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/17/2018
3:29 PM
DanDrit Biotech USA (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel